Long-term effects of ertugliflozin (ERTU) on liver enzymes and indices in patients with type 2 diabetes: analyses from VERTIS CV Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Corbin, K. D.; Dagogo-Jack, S.; Cannon, C. P.; Charbonnel, B.; Cherney, D. Z. I.; Cosentino, F.; McGuire, D. K.; Shih, W. J.; Frederich, R.; Liu, J.; Pong, A.; Cater, N. B.; Pratley, R. E.

authors

Publication Date

  • September 1, 2021

webpage

published in

category

start page

  • 218

end page

  • 219

volume

  • 64

issue

  • SUPPL 1